See other companies on Welcome to the Jungle

Vertex

Biotechnology company

Vertex logo
1001+ employees
  • Healthcare
  • B2B
  • Biology
  • Science
South Boston Waterfront, Boston, MA

Company mission

To invest in scientific innovation to create transformative medicines for people with serious diseases.

Our take

Vertex is a biotechnology company that supports the research and discovery of novel medicines for life-threatening and hard-to-treat diseases. Founded back in 1989, it has achieved many successes over the years including developing breakthrough medicines to treat the underlying cause of cystic fibrosis, and winning awards such as the Robert J. Beall Therapeutics Development Award.

Though the company's specific approach is guarded, Vertex claims to leverage a strong toolkit of technologies, combining this with expertise in the field to push for faster development cycles and more effective results. It has, currently in development, a number of possible treatments for the likes of sickle cell disease, kidney disease, and type 1 diabetes.

Boasting a strong financial year in 2023, the company shows no signs of stopping as it pursues further accreditations for its existing medicines, and moves forwards with development pipelines for possible future products.

Steph headshot

Steph

Company Specialist at Welcome to the Jungle

Benefits

  • Health benefits
  • Generous time off
  • Retirement planning
  • Flexible work policies
  • Mental health and wellness initiatives
  • On-demand virtual childcare
  • Additional time off so you can take care of yourself and your loved ones

Company values

  • We have a unique culture that takes a scientific approach to solving problems
  • We place value on creative solutions and personal growth and development
  • Every person and every idea matter

Funding (last 2 of 3 rounds)

Mar 2009

$2.4m

LATE VC

Jul 1989

$5.8m

LATE VC

Total funding: $17.2m

This company has top investors

Leadership

Reshma Kewalramani

(CEO & President, not founder)

Began working for the company in 2017 as an SVP, going on to become EVP and Chief Medical Officer before taking up the roles of CEO and President. Prior to Vertex, they spent 12 years at Amgen, ultimately as VP (Head US Medical Organization).